Kappa opioid inhibition of morphine and cocaine self-administration in rats
References (20)
- et al.
The kappa agonists PD117302 and U50488 produce a biphasic effect on 24 hour food intake in the rat
Neuropharmacology
(1987) - et al.
U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens
Neurosci. Lett.
(1994) - et al.
The role of mu- and kappa-opioid receptors in cocaine-induced conditioned place preference
Jap. J. Pharmacol.
(1992) Long-term intravenous infusion
- et al.
The kappa-opioid U-50,488H suppresses the initiation of nocturnal spontaneous drinking in normally hydrated rats
Psychopharmacology
(1992) - et al.
Evidence that the aversive effects of opioid antagonists and κ-agonists are centrally mediated
Psychopharmacology
(1989) - et al.
Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies
J. Pharmacol. Exp. Ther.
(1993) - et al.
Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats
- et al.
Blockade of morphine reward through the activation of κ-opioid receptors in mice
Neuropharmacology
(1993) - et al.
Changes in morphine self-administration after brainstem lesions in rats
Psychopharmacology
(1977)
There are more references available in the full text version of this article.
Cited by (200)
Opioid modulation of prefrontal cortex cells and circuits
2024, NeuropharmacologyA systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse
2022, European Journal of Medicinal ChemistryCitation Excerpt :KOR agonists, such as salvinorin A and salvindolin, have also provided benefits in the treatment of anxiety and depression [11–13]. Furthermore, KOR agonists can block the rewarding effects of morphine [14] and psychostimulants such as cocaine [14–16]; therefore, they possess therapeutic potential in the treatment of drug abuse. Meanwhile, KOR antagonists have also shown efficacy in the treatment of anxiety and depression [17].
Kappa-opioid receptor activation reinstates nicotine self-administration in mice
2022, Addiction NeuroscienceSamidorphan, an opioid receptor antagonist, attenuates drug-induced increases in extracellular dopamine concentrations and drug self-administration in male Wistar rats
2021, Pharmacology Biochemistry and Behavior
Copyright © 1995 Published by Elsevier B.V.